# Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm

Study · id `cardio:ct-nct02675205` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02675205](<https://clinicaltrials.gov/study/NCT02675205>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02675205

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02675205. Randomized; no masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2020-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02675205, source copy `cardio:ctgov-nct02675205-2021-07-16`, retrieved 2026-11-18)
- Started: 2015-12 (actual) (ClinicalTrials.gov record NCT02675205, source copy `cardio:ctgov-nct02675205-2021-07-16`, retrieved 2026-11-18)
- Primary completion: 2020-07 (actual) (ClinicalTrials.gov record NCT02675205, source copy `cardio:ctgov-nct02675205-2021-07-16`, retrieved 2026-11-18)
- Completion: 2020-12 (actual) (ClinicalTrials.gov record NCT02675205, source copy `cardio:ctgov-nct02675205-2021-07-16`, retrieved 2026-11-18)
- Countries: France (ClinicalTrials.gov record NCT02675205, source copy `cardio:ctgov-nct02675205-2021-07-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02675205-2021-07-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm
- Acronym: TIC-TAC
- Condition: Cerebral Aneurysm
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Ticagrelor
- Intervention (Drug): aspirin
- Lead sponsor: Fondation Ophtalmologique Adolphe de Rothschild
- Lead sponsor class: NETWORK

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)

## Provenance

Content hash: e476b73783e7fea0399a9ce1c3d1eb9f62e222b3b51d0e42f6d7ffa1d3812b1c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
